WO2026133214 - FAP TARGETING COMPOUNDS AND CONJUGATES THEREOF
National phase entry is expected:
Publication Number
WO/2026/133214
Publication Date
25.06.2026
International Application No.
PCT/IB2025/063093
International Filing Date
17.12.2025
Title **
[English]
FAP TARGETING COMPOUNDS AND CONJUGATES THEREOF
[French]
COMPOSÉS CIBLANT LA FAP ET CONJUGUÉS DE CEUX-CI
Applicants **
NOVARTIS AG
Inventors
ACKER, Vincent Jean François
BAUMANN, Anja
BERST, Frédéric
CLEMENTE, Gonçalo dos Santos
DUMELIN, Christoph
FISCHER, Matteo
GOLOSOV, Andrei Alexandrovich
HOLZER, Philipp
KIEFFER, Laurence
MAURO, Emanuele
MEIER, Peter
PARK, Danielle Rose
RESCHKE, Markus Oliver
SELLNER, Holger
STACHYRA, Thérèse-Marie
Priority Data
63/736,785
20.12.2024
US
63/837,446
02.07.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 8208 | |
| EPO | Filing, Examination, Granting | 123697 | |
| Japan | Filing, Examination, Granting | 5014 | |
| South Korea | Filing, Examination, Granting | 9191 | |
| USA | Filing, Examination, Granting | 30840 |
Total:
176,950
Contact Us
Abstract[English]
Described herein are compounds targeting fibroblast activation protein (FAP), and their incorporation into compounds for radioligand imaging and therapies, as well as methods and/or uses of such compounds for the imaging, treatment and/or prevention of FAP- implicated diseases and disorders.[French]
Sont décrits ici des composés ciblant la protéine d'activation des fibroblastes (FAP), ainsi que leur incorporation dans des composés destinés à l'imagerie par radioligands et aux thérapies associées, de même que des méthodes et/ou des utilisations de ces composés pour l'imagerie, le traitement et/ou la prévention de maladies et de troubles impliquant la FAP.